The purpose of this study was to examine the safety and efficacy of interventional catheterization performed early after congenital heart surgery. BACKGROUND Transcatheter interventions performed in the early postoperative period are viewed as high risk. To date, there have been limited published data regarding these procedures.
Over the last several decades, transcatheter interventions have become a mainstay in the treatment of children with congenital heart disease. The risk in performing these procedures is generally low, although certain interventions performed in selected patient populations are associated with an increased risk of complications and death (1) (2) (3) (4) . There is little published data regarding catheterization and transcatheter intervention performed on patients early in the postoperative period, especially the critically ill infant. Beginning in 1995, we adopted a programmatic philosophy that any child could safely undergo cardiac catheterization, regardless of the time elapsed from cardiac surgery or degree of illness, and that a variety of transcatheter interventions could be safely and effectively performed in this high-risk population. The purpose of this study was to examine the results of this approach.
METHODS
Study patients. Medical records and catheterization data of all patients undergoing catheterization Ͻ6 weeks after congenital heart surgery from August 1995 to January 2001 were reviewed. The decision to perform a catheterization and, subsequently, an intervention were made by a multidisciplinary team including an interventional cardiologist, cardiac surgeon, and cardiac intensivist. Only patients in whom it was thought that delaying catheterization would prove detrimental to their clinical course were taken for early catheterization. Technique. Cases were performed using general anesthesia in a bi-plane digital laboratory with the capacity to perform rapid table-side quantitative measurements, image enhancement, and dynamic road-mapping (Seimens, Hicor, Ehrlangen, Germany). A pediatric interventional cardiologist performed all cases with a cardiac intensivist, pediatric cardiac anesthesiologist, congenital heart surgeon, and operating room team in attendance or immediately available. For patients at exceptionally high risk, a cardiopulmonary support (CPS) unit was kept in the laboratory to allow for rapid initiation of cardiopulmonary bypass should it become necessary (5). Ventilatory, perfusion, and inotropic strategies were managed jointly by anesthesiology, cardiology, and when appropriate, a perfusion team. For patients requiring CPS, flow rates were lowered during angiographic injections and hemodynamic measurements to maximize diagnostic information. Vascular/septal occlusion proce-dures and palliative balloon pulmonary valvulotomies were performed using standard techniques (6, 7) . Newly created suture lines were crossed with high torque floppy-tipped guide wires in an effort to decrease the risk of suture line disruption. Completely occluded vessels and shunts were accessed with a hydrophilic guide wire (Terumo glide wire, Boston Scientific, Natick, Massachusetts) directed across the occlusion, followed by balloon angioplasty Ϯ stent placement (Fig. 1) . In general, stents with the largest potential ultimate diameter were used to allow for future expansion (Palmaz P188 and P308, Cordis, Miami Lakes, Florida). In selected neonatal cases, it was felt that these large stents and their accompanying rigid delivery systems presented too great a risk of suture line disruption/vessel rupture, and lower profile stent systems (Corinthian 124B, Palmaz P104, Cordis) were used. It was recognized that these stents have a maximum diameter of 12 mm and may eventually need to be surgically removed or enlarged; however, we decided that the critically ill nature of these infants justified this approach. In some cases, alternative vascular access was obtained surgically to facilitate catheter passage and stent placement. These included right and left carotid arterial cannulation as well as sheath placement directly into
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ϭ cardiopulmonary support ECMO ϭ extracorporeal membrane oxygenators mBTS ϭ modified Blalock-Taussig shunt PA ϭ pulmonary artery right ventricular pulmonary artery (PA) homograft conduits. These homograft sheath placements were performed in children with an open sternum to gain access to modified systemic PA shunts and branch PAs (Fig. 2) . After stent implantation, sheath insertion sites were surgically repaired. After catheterization, all patients returned to a pediatric cardiac intensive care unit.
Criteria for procedural success. Interventional procedures were considered as successful or unsuccessful based on previously published criteria (Table 1 ). In addition, due to the unique clinical indications for intervention in some of the patients, other clinical criteria such as the ability to separate from CPS within 24 h of the procedure and freedom from re-operation for cyanosis were considered indicators of success. Statistical analysis. Arterial diameters before and after angioplasty or stent placement were compared using a paired t test. A value p Ͻ 0.01 was considered significant.
RESULTS
Sixty-six catheterizations were performed in 62 patients, median weight, 4.7 kg (2.3 to 45 kg); median age, four months (2 days to 11 years); and median time, nine days (0 to 42 days) from their last surgery. Demographic data and indications for catheterization are summarized in Tables 2  and 3 . Patients requiring an intervention were catheterized at a median of six days after surgery. Seventy-one percent of these patients underwent catheterization Ͻ14 days after surgery and 91% Ͻ4 weeks after surgery. Patient diagnoses and surgical procedures performed are listed in Table 4 . At the time of catheterization, 61% were mechanically ventilated, 47% were receiving inotropic support, and 12% required mechanical CPS. While there was a wide range of diagnoses in this series, patients with single ventricle variants comprised nearly half (49%), followed by patients with pulmonary atresia, and ventricular septal defect or tetralogy of Fallot with hypoplastic PAs (22%). These two groups of patients required interventional procedures on a more frequent basis (single ventricle 56%, pulmonary atresia 92%) when compared with the remainder of the patients (22%).
In total, 50 interventional procedures were performed in 35 patients (Table 5) . Success rates by procedure were: angioplasty, 100%; stent implantation, 87%; vascular/septal occlusion, 100%; palliative valvotomy, 75%. There was no procedure-related mortality. Thirty-day survival and sur- 
vival to discharge was 83% and 80%, respectively, for patients requiring an intervention. Thirty (60%) interventions involved either angioplasty or stent implantation. The majority of these (19 of 30) were performed Ͻ48 h after surgery including three patients who went directly from the operating room to the catheterization laboratory.
A total of 87% (26 of 30) of angioplasty/stent procedures involved recently created anastomotic sites, across a variety of native and prosthetic materials (Table 6 ). Balloon/ stenosis ratio averaged 2.5 Ϯ 0.9 (range, 1.4 to 4.4). Vessel diameter increased from 3.2 Ϯ 2.9 mm to 5.9 Ϯ 3.6 mm (p Ͻ 0.001). In no case was there evidence of suture line disruption, vascular rupture, or transmural tear.
Nine children underwent catheterization while requiring CPS. In all cases, a specially designed CPS circuit designed to facilitate rapid implementation and transport was utilized. The system features active venous drainage and heparin-bonded tubing, thus eliminating the need for gravity-dependent drainage and systemic anticoagulation. Five of these patients underwent interventional procedures including placement of PA stents (six patients), angioplasty of an occluded modified Blalock-Taussig shunt (mBTS) (one patient), right PA angioplasty (one patient), and coil occlusion of a large aorto-pulmonary collateral (one patient). There were no complications involving transport, catheter manipulation around CPS cannulas, or functioning of the CPS unit during the catheterization. Six of nine (67%) patients successfully separated from CPS, and five (56%) survived to discharge. Two of the five intervention patients died shortly after separation from CPS after successful interventions. Both cases involved neonates with shunt-dependent pulmonary blood flow and complete occlusion or severe stenosis of the shunt. Neither child was able to separate from bypass, and both were maintained on CPS Ͼ24 h before adequate pulmonary blood flow was restored in the catheterization laboratory. One infant developed immediate and profound reperfusion pulmonary edema and pulmonary hemorrhage leading to death. The other continued to have diminished renal function and depressed cardiac function, which prevented successful ASD ϭ atrial septal defect; AVSD ϭ atrioventricular septal defect; BDCPA ϭ bidirectional cavopulmonary anastomosis; BTS ϭ Blalock-Taussig shunt; HLHS ϭ hypoplastic left heart syndrome; PA ϭ pulmonary artery; PDA ϭ patent ductus arteriosus; PAIVS ϭ pulmonary atresia/intact ventricular septum; PAVSD ϭ pulmonary atresia/ventricular septal defect; PS ϭ pulmonary stenosis; RVOT ϭ right ventricular outflow tract; TAPVR ϭ total anomalous pulmonary venous return; TGA ϭ transposition of great arteries; TOF ϭ teratology of Fallot; VSD ϭ ventricular septal defect. 
Catheterization After Congenital Heart Surgery weaning from CPS. Three major adverse events were noted. A single instance of stent migration occurred in a child requiring CPS who received two right PA stents. The more distal was placed uneventfully; however, the proximal stent migrated back into the main PA. This stent was surgically retrieved and replaced under direct vision using videoscopic guidance. Following this, the patient separated from CPS and was ultimately discharged home. There was a single cerebral infarction after stent implantation into an occluded mBTS via a percutaneous approach from the right carotid artery (previously published) (8) . This patient arrived in the catheterization laboratory on significant inotropic support and receiving cardiopulmonary resuscitation. After stent placement, the patient recovered and was discharged from the hospital. Subsequently, steady neurologic improvement has been observed, and the patient has successfully undergone completion of a total cavopulmonary circulation. A third infant with a severe form of pulmonary atresia, ventricular septal defect, and multiple aorto-pulmonary collaterals who had undergone right ventricular outflow reconstruction was catheterized due to systemic hypotension and pulmonary over-circulation believed secondary to a large collateral. Transcatheter occlusion of the collateral resulted in markedly improved hemodynamics but left the patient with a moderate stenosis of the left PA secondary to protrusion of the coil into the lumen of the distal left PA. The patient was subsequently discharged and eventually underwent successful complete repair. Further intervention to correct the left PA stenosis is planned.
DISCUSSION
Interventional catheterization has become a mainstay in the treatment of many postoperative lesions such as branch pulmonary artery stenosis, conduit obstruction, and recurrent coarctation of the aorta. Improvements in catheter technology and techniques have allowed the application of many of these techniques to even the smallest of neonates (4) . Despite these advances, it is our perception that transcatheter interventions at times may be avoided in the early postoperative period because they may be perceived to be associated with excessive risk. These perceived risks may include difficulties transporting these critically ill patients, concerns regarding worsening clinical status as a result of the procedure, and fear of disruption of recently placed suture lines (9) . It is commonly thought that a minimum of six weeks must pass after cardiac surgery to allow for adequate formation of scar tissue around new anastomotic sites before an intervention can safely be attempted. There are, however, no studies to support this contention. This series reviews an experience with 66 consecutive catheterizations performed in children Ͻ6 weeks after heart surgery. Multi-disciplinary team approach. Intuitively, the risk of catheterizing children early after surgery, particularly when they are critically ill, is higher than that of healthy children. Additionally, a large percentage of postoperative patients are neonates, a group known to be at increased risk for transcatheter intervention (4) . In order to minimize risk, procedures in this series were performed using general anesthesia administered by a pediatric anesthesiologist experienced in congenital heart disease. This prevented airway compromise and greatly improved our ability to manage these critically ill, often unstable children. The presence of a pediatric cardiac intensivist and cardiac surgeon allowed for immediate medical and/or surgical intervention and consultation regarding the best treatment modality for a particular patient (catheter intervention vs. surgery vs. medical management). Surgical presence was also useful for clarifying postoperative anatomy, providing alternative routes of vascular access, managing CPS and standby should there be a significant surgical complication such as a vascular rupture. While this approach is labor intensive, the critical nature of these patients and the increased risk associated with early postoperative catheterization justifies it. Angioplasty and stent implantation. One striking finding in this series was the absence of any identifiable suture line disruption, significant vascular tear, or death associated with angioplasty and/or stent placement. This contrasts with a report by Rosales et al. (9) where balloon angioplasty of the branch PAs in the early postoperative period was associated with a 20% mortality. The deaths in that study were believed to be secondary to vascular disruption with resultant bleeding. The balloon/stenosis ratio used was nearly identical to ours, making balloon size alone unlikely to be the reason for the reported deaths. It is possible that interinstitutional variations in surgical and/or interventional techniques may be responsible for the different outcomes. Additionally, the current study is more recent and may reflect the evolution of equipment and technique. It is possible that the presence of a cardiac surgical team with the ability to place patients on CPS quickly may have prevented some of the deaths described in that series. Our experience suggests that a variety of freshly sutured materials can undergo angioplasty and stent implantation without resultant vascular disruption. There are several potential reasons for this. Suture lines were constructed of polypropylene monofilament (Prolene, Ethicon Inc., Summerville, New Jersey) sewn in a continuous fashion. Prolene can elongate as much as 34% before the breaking. In addition, there is an enlargement of the circumference of the suture line (increased distance between parallel throws) in response to balloon inflation, which prevents suture breakage within the limits of the angioplasties performed. We believe that continuous Prolene suture lines can be safely 
